exactly, people who are NOT intrigued or excited by this announcement dont understand the biotech space and how difficult it is to develop to new drugs especially for rare diseases such as FSGS. Dimerix should be commended for their efforts before people clamour about the SP and how much profits they will make or whining about the recent CR....cmon this is a game changer and will help people in the near future
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study, page-57
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
0.040(8.89%) |
Mkt cap ! $269.6M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 50.5¢ | 46.0¢ | $2.255M | 4.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 21052 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |